azasetron has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, J; Funaguchi, N; Iihara, H; Ito, F; Itoh, Y; Kamiya, F; Minatoguchi, S; Ohno, Y; Yamada, M; Yanase, K | 1 |
| Abiko, K; Baba, T; Hamanishi, J; Imai, S; Konishi, I; Koshiyama, M; Matsumura, N; Yamaguchi, K; Yamanoi, K; Yoshioka, Y | 1 |
2 trial(s) available for azasetron and carboplatin
| Article | Year |
|---|---|
A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Carboplatin; Female; Granisetron; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Oxazines; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 2012 |
Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Bridged Bicyclo Compounds, Heterocyclic; Carboplatin; Dexamethasone; Female; Humans; Middle Aged; Morpholines; Nausea; Ovarian Neoplasms; Oxazines; Paclitaxel; Pre-Exposure Prophylaxis; Prospective Studies; Vomiting | 2017 |